Trimedx Named Visionary Leader in Healthcare Cybersecurity

Indianapolis, Indiana, Sept. 30, 2026 /CourierPR/ -- Trimedx, a leading clinical asset performance company, has been recognized as a Visionary Leader in the Frost Radar™: Healthcare Infrastructure Cybersecurity in the United States, 2026 report from Frost & Sullivan. The Frost & Sullivan report evaluated more than 50 qualified participants and selected 15 companies for inclusion based on strong growth, innovation leadership, and measurable market impact. Among these, Trimedx stood out for its transformative approach to healthcare infrastructure cybersecurity.

The Frost & Sullivan report highlighted Trimedx’s extensive medical device data, which enables health systems to evaluate cyber-risk alongside maintenance, utilization, obsolescence, and clinical impact. Trimedx received an Innovation Index score of 5.00 and a Growth Index score of 4.00 (on a scale of 0 to 5). The company’s extensive medical device data allows health systems to integrate cybersecurity with operational and clinical realities, providing a comprehensive view of medical device security.

Trimedx’s Visionary Leader designation underscores its unique ability to connect cybersecurity with healthcare technology management, medical device lifecycle expertise, and capital planning. The company’s cybersecurity program supports more than 7,000 locations and approximately 825,000 medical devices. Trimedx performs nearly 10,000 medical device patches each month, and its cybersecurity business has grown by more than 20% annually for at least the past three years, according to the report.

The Frost & Sullivan report also commended Trimedx for its use of nearly 30 years of medical device service experience and a structured repository of service history from more than 7.4 million devices. This data enables Trimedx to support AI-enabled capabilities across cybersecurity, clinical asset management, and capital planning. By connecting cyber-risk with device age, operating system status, utilization, maintenance performance, and estimated replacement costs, Trimedx can help healthcare organizations incorporate cybersecurity into broader medical device lifecycle and capital planning decisions.

The Frost & Sullivan report further noted that Trimedx extends into the operational “last mile,” including patch deployment, risk treatment, governance, and medical device lifecycle management. The company’s ability to connect cyber-risk with healthcare technology management and operational execution creates a differentiated approach to helping health systems protect medical devices and strengthen resilience.

Trimedx’s cybersecurity services and TMX Protect are available for further information. Trimedx is an industry-leading clinical asset performance company, helping health systems transform medical devices from a cost into a source of strategic advantage. Built by providers, for providers, Trimedx’s experts deliver clinical engineering, clinical asset management, and cybersecurity while continuously capturing intelligence from the clinical floor. Powered by TMX, the company’s clinical asset intelligence platform built on a service history of more than 7.4 million devices with data on 90-95% of in-use U.S. medical equipment, Trimedx turns unmatched intelligence into predictive insights that help prevent failures before they happen. The result is lower operating expenses, optimized capital investments, stronger medical device safety and security, and more resources available for patient care, because in critical environments, all systems are critical.